Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2522378rdf:typepubmed:Citationlld:pubmed
pubmed-article:2522378lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2522378lifeskim:mentionsumls-concept:C0035078lld:lifeskim
pubmed-article:2522378lifeskim:mentionsumls-concept:C0031140lld:lifeskim
pubmed-article:2522378pubmed:issue1lld:pubmed
pubmed-article:2522378pubmed:dateCreated1989-5-3lld:pubmed
pubmed-article:2522378pubmed:abstractTextDuring the 6-year period 1981-1987, 309 patients started chronic ambulatory peritoneal dialysis (CAPD), of whom 75 (24%) had diabetes. Despite severe peripheral vascular problems (20%), ischaemic heart disease (90%), and complete blindness (21%) the 1-year patient survival on CAPD was 88%. The actuarial patient survival for diabetic patients was similar to that of the non-diabetic cohort over the first 18 months but fell to 48% (compared to 70% in non-diabetic patients) at 3 years. Complications associated with CAPD, including the incidence of peritonitis, were no different between the diabetic and non-diabetic patient populations. Successful treatment for end-stage renal disease (ESRD) in diabetic patients can be achieved and justified in a liberal selection programme for the treatment of diabetic ESRD.lld:pubmed
pubmed-article:2522378pubmed:languageenglld:pubmed
pubmed-article:2522378pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2522378pubmed:citationSubsetIMlld:pubmed
pubmed-article:2522378pubmed:statusMEDLINElld:pubmed
pubmed-article:2522378pubmed:issn0742-3071lld:pubmed
pubmed-article:2522378pubmed:authorpubmed-author:MichaelJJlld:pubmed
pubmed-article:2522378pubmed:authorpubmed-author:McGonigleRRlld:pubmed
pubmed-article:2522378pubmed:authorpubmed-author:AduDDlld:pubmed
pubmed-article:2522378pubmed:authorpubmed-author:BeamanMMlld:pubmed
pubmed-article:2522378pubmed:authorpubmed-author:BerisaFFlld:pubmed
pubmed-article:2522378pubmed:issnTypePrintlld:pubmed
pubmed-article:2522378pubmed:volume6lld:pubmed
pubmed-article:2522378pubmed:ownerNLMlld:pubmed
pubmed-article:2522378pubmed:authorsCompleteYlld:pubmed
pubmed-article:2522378pubmed:pagination67-70lld:pubmed
pubmed-article:2522378pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2522378pubmed:meshHeadingpubmed-meshheading:2522378-...lld:pubmed
pubmed-article:2522378pubmed:meshHeadingpubmed-meshheading:2522378-...lld:pubmed
pubmed-article:2522378pubmed:meshHeadingpubmed-meshheading:2522378-...lld:pubmed
pubmed-article:2522378pubmed:meshHeadingpubmed-meshheading:2522378-...lld:pubmed
pubmed-article:2522378pubmed:meshHeadingpubmed-meshheading:2522378-...lld:pubmed
pubmed-article:2522378pubmed:meshHeadingpubmed-meshheading:2522378-...lld:pubmed
pubmed-article:2522378pubmed:articleTitleThe treatment of diabetic renal failure by continuous ambulatory peritoneal dialysis.lld:pubmed
pubmed-article:2522378pubmed:affiliationQueen Elizabeth Hospital, Birmingham, UK.lld:pubmed
pubmed-article:2522378pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2522378lld:pubmed